News
SPARC developing drugs for allergies, inflammation & seizures
articles.economictimes.indiatimes.com
[Economic Times] - The company is undertaking various studies to look into the safety and efficacy of its molecules SUN-1334H, SUN-597 and SUN-44, Sun Pharma Advanced Research Company Chairman and Managing Director Dilip Shanghvi said. "Our lead molecule
Sun Pharma consolidated Q1 profit jumps 59%
www.myiris.com
[Myiris.com] - Dilip Shanghvi, managing director of the company said, ``Over the years, we have focused on building a consistent, predictable and profitable business. The performance this quarter is once again a reflection of this strength. The year has begun well as
Sun Pharma Q1 net profit rises 59%
businesstoday.intoday.in
[Business Today] - "Over the years, we have focused on building a consistent, predictable and profitable business. The performance this quarter is once again a reflection of this strength," Sun Pharma Managing Director Dilip Shanghvi said. During the quarter, the company
dilip shanghvi: Latest News, Videos and dilip shanghvi Photos |...
timesofindia.indiatimes.com
Latest dilip shanghvi News, Photos, Blogposts, Videos and Wallpapers. Explore dilip shanghvi profile at Times of India
sorted by relevance / date